









市場行情
/
股票
/
nasdaq-amgn
/

Amgen Inc

AMGN

327.380USD

+2.960+0.91%

收盤 12/19, 16:00（美東）報價延遲15分鐘

176.29B總市值

25.14本益比TTM



Amgen Inc

327.380

+2.960+0.91%

概覽公司財務分析

概覽

公司

財務

分析

關於 Amgen Inc 公司

Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.

Amgen Inc簡介



公司代碼AMGN

公司名稱Amgen Inc

上市日期Jun 17, 1983

CEOBradway (Robert A)

員工數量28000

證券類型Ordinary Share

年結日Jun 17

公司地址One Amgen Center Drive

城市THOUSAND OAKS

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編91320-1799

電話18054471000

網址https://www.amgen.com/

公司代碼AMGN

上市日期Jun 17, 1983

CEOBradway (Robert A)

Amgen Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Robert A. (Bob) Bradway

Chairman of the Board, President, Chief Executive Officer

566.37K

+1.52%

Mr. Esteban Santos

Executive Vice President - Operations

69.05K

+3.06%

Mr. Murdo Gordon

Executive Vice President - Global Commercial Operations

34.82K

-16.50%

Dr. Tyler Jacks

Independent Director

17.19K

+4.94%

Mr. Derek Miller

Senior Vice President - Human Resources

9.93K

+6.57%

Dr. Brian J. Druker, M.D.

Independent Director

7.57K

+11.97%

Dr. Wanda M. Austin, Ph.D.

Independent Director

7.35K

+12.36%

Ms. Rachna Khosla

Senior Vice President - Business Development

6.66K

-14.35%

Ms. Nancy A. Grygiel

Senior Vice President, Chief Compliance Officer

6.04K

Dr. Michael V. Drake, M.D.

Independent Director

4.89K

+4.69%

名稱

名稱/職務

職務

持股

持股變動

Mr. Robert A. (Bob) Bradway

Chairman of the Board, President, Chief Executive Officer

566.37K

+1.52%

Mr. Esteban Santos

Executive Vice President - Operations

69.05K

+3.06%

Mr. Murdo Gordon

Executive Vice President - Global Commercial Operations

34.82K

-16.50%

Dr. Tyler Jacks

Independent Director

17.19K

+4.94%

Mr. Derek Miller

Senior Vice President - Human Resources

9.93K

+6.57%

Dr. Brian J. Druker, M.D.

Independent Director

7.57K

+11.97%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Other products

1.69B

18.41%

Prolia

1.12B

12.22%

Repatha

696.00M

7.58%

Otezla

618.00M

6.73%

Enbrel

604.00M

6.58%

其他

4.45B

48.47%

地區USD

名稱

營收

佔比

5.93B

64.59%

ROW

2.32B

25.32%

業務

地區

業務USD

名稱

營收

佔比

Other products

1.69B

18.41%

Prolia

1.12B

12.22%

Repatha

696.00M

7.58%

Otezla

618.00M

6.73%

Enbrel

604.00M

6.58%

其他

4.45B

48.47%

股東統計

更新時間: 11月15日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.96%

State Street Investment Management (US)

5.44%

BlackRock Institutional Trust Company, N.A.

5.30%

Capital International Investors

3.56%

Capital World Investors

3.49%

其他

72.25%

持股股東

佔比

The Vanguard Group, Inc.

9.96%

State Street Investment Management (US)

5.44%

BlackRock Institutional Trust Company, N.A.

5.30%

Capital International Investors

3.56%

Capital World Investors

3.49%

其他

72.25%

股東類型

持股股東

佔比

Investment Advisor

53.48%

Investment Advisor/Hedge Fund

19.12%

Research Firm

4.87%

Pension Fund

2.19%

Bank and Trust

1.99%

Sovereign Wealth Fund

1.18%

Insurance Company

0.63%

Hedge Fund

0.42%

Individual Investor

0.17%

其他

15.96%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

4407

451.47M

85.20%

+63.91K

2025Q3

4486

451.61M

85.29%

-1.24M

2025Q2

4487

452.85M

84.91%

+2.52M

2025Q1

4500

450.78M

83.12%

+3.88M

2024Q4

4470

440.57M

82.15%

+6.55M

2024Q3

4290

435.41M

82.39%

-1.01M

2024Q2

4260

436.06M

82.34%

+1.04M

2024Q1

4169

435.45M

81.98%

-3.93M

2023Q4

4130

433.32M

81.14%

+5.55M

2023Q3

3960

428.67M

80.98%

-560.79K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

53.86M

10%

+393.81K

+0.74%

Aug 29, 2025

State Street Investment Management (US)

29.36M

5.45%

+177.03K

+0.61%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

28.83M

5.36%

+326.43K

+1.15%

Jun 30, 2025

Capital International Investors

18.91M

3.51%

+3.78M

+24.95%

Jun 30, 2025

Capital World Investors

16.86M

3.13%

+157.99K

+0.95%

Jun 30, 2025

Charles Schwab Investment Management, Inc.

12.89M

2.4%

+687.74K

+5.63%

Jun 30, 2025

Geode Capital Management, L.L.C.

13.02M

2.42%

+291.27K

+2.29%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

11.01M

2.04%

-38.88K

-0.35%

Aug 31, 2025

PRIMECAP Management Company

10.63M

1.97%

-1.76M

-14.18%

Jun 30, 2025

Morgan Stanley Smith Barney LLC

8.82M

1.64%

+91.95K

+1.05%

Jun 30, 2025

持股ETF



更新時間: 12月1日週一

機構名稱

佔比

VanEck Biotech ETF

12.81%

FT Vest DJIA Dogs 10 Target Income ETF

12.23%

ProShares Ultra Nasdaq Biotechnology

8.42%

Invesco Nasdaq Biotechnology ETF

8.35%

Simplify Health Care ETF

7.93%

iShares Biotechnology ETF

7.08%

Invesco Dow Jones Industrial Average Dividend ETF

6.24%

Amplify Weight Loss Drug & Treatment ETF

5.87%

Invesco Pharmaceuticals ETF

5.05%

Invesco Biotechnology & Genome ETF

5.01%

VanEck Biotech ETF

佔比12.81%

FT Vest DJIA Dogs 10 Target Income ETF

佔比12.23%

ProShares Ultra Nasdaq Biotechnology

佔比8.42%

Invesco Nasdaq Biotechnology ETF

佔比8.35%

Simplify Health Care ETF

佔比7.93%

iShares Biotechnology ETF

佔比7.08%

Invesco Dow Jones Industrial Average Dividend ETF

佔比6.24%

Amplify Weight Loss Drug & Treatment ETF

佔比5.87%

Invesco Pharmaceuticals ETF

佔比5.05%

Invesco Biotechnology & Genome ETF

佔比5.01%

分紅派息



近5年累計派現 21.35B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Oct 31, 2025

AMGN.NB Final Cash Dividend of gross USD 2.38 paid on Dec 12, 2025 going ex on Nov 21, 2025

Nov 21, 2025

Dec 12, 2025

Nov 21, 2025

Aug 01, 2025

AMGN.NB Interim Cash Dividend of gross USD 2.38 paid on Sep 12, 2025 going ex on Aug 22, 2025

Aug 22, 2025

Sep 12, 2025

Aug 22, 2025

Mar 04, 2025

AMGN.NB Interim Cash Dividend of gross USD 2.38 paid on Jun 06, 2025 going ex on May 16, 2025

May 16, 2025

Jun 06, 2025

May 16, 2025

Dec 10, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.38 paid on Mar 07, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 07, 2025

Feb 14, 2025

Oct 25, 2024

AMGN.NB Final Cash Dividend of gross USD 2.25 paid on Dec 09, 2024 going ex on Nov 18, 2024

Nov 18, 2024

Dec 09, 2024

Nov 18, 2024

Aug 02, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Sep 06, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Sep 06, 2024

Aug 16, 2024

Mar 06, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Jun 07, 2024 going ex on May 16, 2024

May 17, 2024

Jun 07, 2024

May 16, 2024

Dec 12, 2023

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Mar 07, 2024 going ex on Feb 15, 2024

Feb 16, 2024

Mar 07, 2024

Feb 15, 2024

Oct 24, 2023

AMGN.NB Final Cash Dividend of gross USD 2.13 paid on Dec 08, 2023 going ex on Nov 16, 2023

Nov 17, 2023

Dec 08, 2023

Nov 16, 2023

Aug 01, 2023

AMGN.NB Interim Cash Dividend of gross USD 2.13 paid on Sep 08, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 08, 2023

Aug 17, 2023

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Amgen Inc的前五大股東是誰？



Amgen Inc的前五大股東如下：
The Vanguard Group, Inc.
持有股份：53.86M
佔總股份比例：10.00%。
State Street Investment Management (US)
持有股份：29.36M
佔總股份比例：5.45%。
BlackRock Institutional Trust Company, N.A.
持有股份：28.83M
佔總股份比例：5.36%。
Capital International Investors
持有股份：18.91M
佔總股份比例：3.51%。
Capital World Investors
持有股份：16.86M
佔總股份比例：3.13%。